Histone deacetylases (HDACs) are essential for the regulation
of
myriad biological processes, and their aberrant function is implicated
in cancer, neurodegeneration, and other diseases. The cytosolic isozyme
HDAC6 is unique among the greater family of deacetylases in that it
contains two catalytic domains, CD1 and CD2. HDAC6 CD2 is responsible
for tubulin deacetylase and tau deacetylase activities, inhibition
of which is a key goal as new therapeutic approaches are explored.
Of
particular interest as HDAC inhibitors are naturally occurring cyclic
tetrapeptides such as Trapoxin A or HC Toxin, or the cyclic depsipeptides
Largazole and Romidepsin. Even more intriguing are larger, computationally
designed macrocyclic peptide inhibitors. Here, we report the 2.0 Å
resolution crystal structure of HDAC6 CD2 complexed with macrocyclic
octapeptide 1. Comparison with the previously reported
structure of the complex with macrocyclic octapeptide 2 reveals that a potent thiolate–zinc interaction made by the
unnatural amino acid (S)-2-amino-7-sulfanylheptanoic
acid contributes to nanomolar inhibitory potency for each inhibitor.
Apart from this zinc-binding residue, octapeptides adopt strikingly
different overall conformations and make few direct hydrogen bonds
with the protein. Intermolecular interactions are dominated by water-mediated
hydrogen bonds; in essence, water molecules appear to cushion the
enzyme–octapeptide interface. In view of the broad specificity
observed for protein substrates of HDAC6 CD2, we suggest that the
binding of macrocyclic octapeptides may mimic certain features of
the binding of macromolecular protein substrates.